These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 17110595)

  • 41. The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro.
    Scholz H; Lund T; Dahle MK; Collins JL; Korsgren O; Wang JE; Foss A
    Diabetologia; 2009 Jul; 52(7):1352-62. PubMed ID: 19415233
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of liver X receptor attenuates endothelin-1 expression in vascular endothelial cells.
    Gao M; Zeng Y; Guan Y; Hu Z; Zhong D; Shen X; Zhang L; Xu Z; Gong W; Zhang Y; Zhang M; Zheng Y; He F
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2299-307. PubMed ID: 23018104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver X receptors (LXR) as therapeutic targets in dyslipidemia.
    Bełtowski J
    Cardiovasc Ther; 2008; 26(4):297-316. PubMed ID: 19035881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LXRalpha activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins.
    Basciano H; Miller A; Baker C; Naples M; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G323-32. PubMed ID: 19497957
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological activation of liver X receptors promotes reverse cholesterol transport in vivo.
    Naik SU; Wang X; Da Silva JS; Jaye M; Macphee CH; Reilly MP; Billheimer JT; Rothblat GH; Rader DJ
    Circulation; 2006 Jan; 113(1):90-7. PubMed ID: 16365197
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes.
    Hanriot D; Bello G; Ropars A; Seguin-Devaux C; Poitevin G; Grosjean S; Latger-Cannard V; Devaux Y; Zannad F; Regnault V; Lacolley P; Mertes PM; Hess K; Longrois D
    Thromb Haemost; 2008 Mar; 99(3):558-69. PubMed ID: 18327405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
    Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
    J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing the effects of LXR agonists on cellular cholesterol handling: a stable isotope tracer study.
    Aravindhan K; Webb CL; Jaye M; Ghosh A; Willette RN; DiNardo NJ; Jucker BM
    J Lipid Res; 2006 Jun; 47(6):1250-60. PubMed ID: 16567856
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global analysis of nuclear receptor expression and dysregulation in human osteoarthritic articular cartilage: reduced LXR signaling contributes to catabolic metabolism typical of osteoarthritis.
    Collins-Racie LA; Yang Z; Arai M; Li N; Majumdar MK; Nagpal S; Mounts WM; Dorner AJ; Morris E; LaVallie ER
    Osteoarthritis Cartilage; 2009 Jul; 17(7):832-42. PubMed ID: 19217805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Knock-down of the oxysterol receptor LXRα impairs cholesterol efflux in human primary macrophages: lack of compensation by LXRβ activation.
    Ishibashi M; Filomenko R; Rébé C; Chevriaux A; Varin A; Derangère V; Bessède G; Gambert P; Lagrost L; Masson D
    Biochem Pharmacol; 2013 Jul; 86(1):122-9. PubMed ID: 23313547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fasting-induced FGF21 is repressed by LXR activation via recruitment of an HDAC3 corepressor complex in mice.
    Archer A; Venteclef N; Mode A; Pedrelli M; Gabbi C; Clément K; Parini P; Gustafsson JÅ; Korach-André M
    Mol Endocrinol; 2012 Dec; 26(12):1980-90. PubMed ID: 23073827
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.
    Wagner BL; Valledor AF; Shao G; Daige CL; Bischoff ED; Petrowski M; Jepsen K; Baek SH; Heyman RA; Rosenfeld MG; Schulman IG; Glass CK
    Mol Cell Biol; 2003 Aug; 23(16):5780-9. PubMed ID: 12897148
    [TBL] [Abstract][Full Text] [Related]  

  • 53. T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR.
    Mitro N; Vargas L; Romeo R; Koder A; Saez E
    FEBS Lett; 2007 May; 581(9):1721-6. PubMed ID: 17418145
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver X receptor agonists inhibit tissue factor expression in macrophages.
    Terasaka N; Hiroshima A; Ariga A; Honzumi S; Koieyama T; Inaba T; Fujiwara T
    FEBS J; 2005 Mar; 272(6):1546-56. PubMed ID: 15752369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of liver x receptor/retinoid X receptor-mediated transcription contributes to the proatherogenic effects of arsenic in macrophages in vitro.
    Padovani AM; Molina MF; Mann KK
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1228-36. PubMed ID: 20339114
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease.
    Koldamova RP; Lefterov IM; Staufenbiel M; Wolfe D; Huang S; Glorioso JC; Walter M; Roth MG; Lazo JS
    J Biol Chem; 2005 Feb; 280(6):4079-88. PubMed ID: 15557325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Negative regulation of Hedgehog signaling by liver X receptors.
    Kim WK; Meliton V; Park KW; Hong C; Tontonoz P; Niewiadomski P; Waschek JA; Tetradis S; Parhami F
    Mol Endocrinol; 2009 Oct; 23(10):1532-43. PubMed ID: 19608643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liver X receptor agonist downregulates hepatic apoM expression in vivo and in vitro.
    Zhang X; Zhu Z; Luo G; Zheng L; Nilsson-Ehle P; Xu N
    Biochem Biophys Res Commun; 2008 Jun; 371(1):114-7. PubMed ID: 18413148
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver X Receptor Regulates Triglyceride Absorption Through Intestinal Down-regulation of Scavenger Receptor Class B, Type 1.
    Briand O; Touche V; Colin S; Brufau G; Davalos A; Schonewille M; Bovenga F; Carrière V; de Boer JF; Dugardin C; Riveau B; Clavey V; Tailleux A; Moschetta A; Lasunción MA; Groen AK; Staels B; Lestavel S
    Gastroenterology; 2016 Mar; 150(3):650-8. PubMed ID: 26602218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. T0901317 is a dual LXR/FXR agonist.
    Houck KA; Borchert KM; Hepler CD; Thomas JS; Bramlett KS; Michael LF; Burris TP
    Mol Genet Metab; 2004; 83(1-2):184-7. PubMed ID: 15464433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.